To compare the novel SCTE-AI to IM testosterone cypionate (IM-TC) in their ability teffectively increase total testosterone (TT) levels as well as evaluating safety profiles bymeasuring E2, HCT, and PSA responses.
Latest Information Update: 01 Nov 2021
At a glance
- Drugs Testosterone cipionate (Primary) ; Testosterone enanthate (Primary)
- Indications Hypogonadism
- Focus Therapeutic Use
- 01 Nov 2021 New trial record
- 25 Oct 2021 Results published in the Journal of Urology